Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Premature Birth 1Patient Compliance 1Neoplasms 1Hirschsprung Disease 1Heart Defects, Congenital 1Congenital Abnormalities 1Child Nutrition Disorders 1Burnout, Psychological 1Burnout, Professional 1Acquired Immunodeficiency Syndrome 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Self Care × 1 year × Clear all
NCT04150120 2026-04-06

eChildHealth

Lund University

Phase NA Completed
720 enrolled

Congenital Abnormalities, Acquired Immunodeficiency Syndrome, Heart Defects, Congenital, Hirschsprung Disease, Neoplasms, Patient Compliance, Child Nutrition Disorders, Premature Birth

NCT07459868 2026-03-11

CARE-ONC

Fundacion Arturo Lopez Perez

Phase NA Not yet recruiting
9 enrolled

Burnout, Psychological, Burnout, Professional

Data powered by HemOnc (CC BY 4.0) Colophon âš¡